share_log

Cooper Companies' (NASDAQ:COO) Investors Will Be Pleased With Their Favorable 46% Return Over the Last Five Years

Cooper Companies' (NASDAQ:COO) Investors Will Be Pleased With Their Favorable 46% Return Over the Last Five Years

庫珀醫療(納斯達克:COO)的投資者將對過去五年中令人滿意的46%回報感到滿意
Simply Wall St ·  10/24 01:35

The main point of investing for the long term is to make money. Furthermore, you'd generally like to see the share price rise faster than the market. But The Cooper Companies, Inc. (NASDAQ:COO) has fallen short of that second goal, with a share price rise of 46% over five years, which is below the market return. On a brighter note, more newer shareholders are probably rather content with the 32% share price gain over twelve months.

長期投資的主要目的是賺錢。此外,您通常希望股價的漲幅超過市場。但庫珀醫療公司(納斯達克股票代碼:COO)未能實現第二個目標,股價在五年內上漲了46%,低於市場回報。值得一提的是,更多新股東可能對過去十二個月的32%股價上漲感到滿意。

Now it's worth having a look at the company's fundamentals too, because that will help us determine if the long term shareholder return has matched the performance of the underlying business.

現在值得更詳細地了解該公司的基本面,因爲這將幫助我們判斷長期股東回報是否與基礎業務的表現相匹配。

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

不可否認的是,市場有時是高效的,但價格並不總是反映潛在的商業表現。一個不完美但簡單的方法來考慮公司市場感知如何改變是比較每股收益(EPS)變化和股價變動。

During five years of share price growth, Cooper Companies actually saw its EPS drop 4.4% per year.

在五年的股價增長中,庫珀醫療公司的每股收益每年實際下降了4.4%。

By glancing at these numbers, we'd posit that the decline in earnings per share is not representative of how the business has changed over the years. Therefore, it's worth taking a look at other metrics to try to understand the share price movements.

通過瀏覽這些數字,我們可以推斷每股收益下降並不代表業務在這些年裏的變化。因此,值得看看其他指標以了解股票價格的變動。

On the other hand, Cooper Companies' revenue is growing nicely, at a compound rate of 9.4% over the last five years. In that case, the company may be sacrificing current earnings per share to drive growth.

另一方面,庫珀醫療的營業收入增長速度不錯,在過去五年中複合增長率爲9.4%。在這種情況下,公司可能正在犧牲當前每股收益來推動增長。

The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).

下面的圖表顯示了收益和營收隨時間的變化情況(通過單擊圖像揭示確切的值)。

big
NasdaqGS:COO Earnings and Revenue Growth October 23rd 2024
納斯達克股票交易所:COO2024年10月23日盈利和營業收入增長

Cooper Companies is well known by investors, and plenty of clever analysts have tried to predict the future profit levels. You can see what analysts are predicting for Cooper Companies in this interactive graph of future profit estimates.

投資者對庫珀醫療耳熟能詳,許多聰明的分析師試圖預測未來的利潤水平。您可以通過觀看庫珀醫療未來利潤預測的互動圖表來了解分析師的預測。

A Different Perspective

不同的觀點

Cooper Companies provided a TSR of 32% over the last twelve months. Unfortunately this falls short of the market return. The silver lining is that the gain was actually better than the average annual return of 8% per year over five year. It is possible that returns will improve along with the business fundamentals. Most investors take the time to check the data on insider transactions. You can click here to see if insiders have been buying or selling.

過去十二個月,庫珀醫療的TSR爲32%。不幸的是,這低於市場回報。美中不足的是,盈利實際上比過去五年平均每年8%的年回報要好。回報隨着業務基本面的改善可能會提高。大多數投資者都會花時間檢查內部交易數據。您可以點擊這裏查看內部人員是否一直在買入或賣出。

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.

當然,您可能在其他地方找到一家出色的企業進行投資。因此,請查看我們預計將實現盈利增長的公司的免費列表。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文所引述的市場回報反映了目前在美國交易所上市的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論